article thumbnail

India’s contract manufacturing gains momentum due to high quality & cost effectiveness: Expert

AuroBlog - Aurous Healthcare Clinical Trials blog

India is strengthening its scope in contract manufacturing as the global customers commend the strengths and dependability of its pharma and biotech sectors.

article thumbnail

Inflationary pressure causes drop-off in contract manufacturing M&A

Pharmaceutical Technology

As several economies deal with inflation, there has been a reduction in deals involving contract manufacturing organisations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

High interest rates will reduce investment in pharma contract manufacturers

Pharmaceutical Technology

During a time when increasingly innovative biologics are being approved and pharma companies are seeking contractors to mitigate the risk of supply chain disruptions, the long-term effects of slowing investment could significantly hinder global pharma manufacturing.

article thumbnail

How PartnerSlate is Digitizing the Food and Beverage Contract Manufacturing Industry

XTalks

The online marketplace PartnerSlate has made waves in the food and beverage contract manufacturing industry, recently securing a $4 million investment to further its mission of connecting food brands and contract manufacturers. This is where San Francisco-based PartnerSlate comes in.

article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

Mahesh Bhalgat, Syngene’s chief operating officer In the US, which has among the highest contract manufacturing rates globally, 140 contract manufacturing organizations have 207 facilities capable of producing active pharmaceutical ingredients (API) for protein and peptide-type biologics.

article thumbnail

Distributed Control System Facilitates Expansion for New Drugs Produced by Contract Manufacturing Organization

Pharma Mirror

Combatting the pandemic has highlighted the importance of the partnership between biopharma organizations and the contract manufacturing organizations (CMOs) that must flexibly handle outsourced production, which can come suddenly and often must quickly be ramped up.

article thumbnail

mRNA: A New Era in Biopharmaceutical Contract Manufacturing Market

Roots Analysis

Given such technical and operational challenges associated with the production of RNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the contract manufacturing service providers to cater to the urgent global demand.